• Home
  • 701P Multicenter analysis of first-line (1L) regimens (BEP vs VIP) in patients (pts) with non-seminomatous germ cell tumors (NSGCTs) who subsequently underwent high-dose chemotherapy (HDCT).

701P Multicenter analysis of first-line (1L) regimens (BEP vs VIP) in patients (pts) with non-seminomatous germ cell tumors (NSGCTs) who subsequently underwent high-dose chemotherapy (HDCT).

Author List
H. Ebrahimi, M. Shodiya, E. Maldonado, T. Othman, R. Barragan-Carrillo, X. Li, A. Rock, A. Tripathi, S.K. Pal, T.B. Dorff, A. Zhumkhawala, R. Tetens Hoeg, C. Oliai, R. Olin, M. Mei, A. Chehrazi-Raffle
Publication
Annals of Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/549262208
Publication Year
2024
Publication Title
H. Ebrahimi, M. Shodiya, E. Maldonado, T. Othman, R. Barragan-Carrillo, X. Li, A. Rock, A. Tripathi, S.K. Pal, T.B. Dorff, A. Zhumkhawala, R. Tetens Hoeg, C. Oliai, R. Olin, M. Mei, A. Chehrazi-Raffle. 701P Multicenter analysis of first-line (1L) regimens (BEP vs VIP) in patients (pts) with non-seminomatous germ cell tumors (NSGCTs) who subsequently underwent high-dose chemotherapy (HDCT). Annals of Oncology. 2024 Sep 1; 35:s540.